Cannabidiol-induced apoptosis is mediated by activation of Noxa in human colorectal cancer cells
- Authors
- Jeong, Soyeon; Yun, Hye Kyeong; Jeong, Yoon A.; Jo, Min Jee; Kang, Sang Hee; Kim, Jung Lim; Kim, Dae Yeong; Park, Seong Hye; Kim, Bo Ram; Na, Yoo Jin; Lee, Sun Il; Kim, Han Do; Kim, Dae Hyun; Oh, Sang Cheul; Lee, Dae-Hee
- Issue Date
- Apr-2019
- Publisher
- ELSEVIER IRELAND LTD
- Keywords
- Marijuana extract; Bcl-2 protein family; ROS; Apoptotic cell death; Colon cancer
- Citation
- CANCER LETTERS, v.447, pp 12 - 23
- Pages
- 12
- Indexed
- SCI
SCIE
SCOPUS
- Journal Title
- CANCER LETTERS
- Volume
- 447
- Start Page
- 12
- End Page
- 23
- URI
- https://scholarworks.korea.ac.kr/kumedicine/handle/2020.sw.kumedicine/2762
- DOI
- 10.1016/j.canlet.2019.01.011
- ISSN
- 0304-3835
1872-7980
- Abstract
- Cannabidiol (CBD), one of the compounds present in the marijuana plant, has anti-tumor properties, but its mechanism is not well known. This study aimed to evaluate the apoptotic action of CBD in colorectal cancer (CRC) cells, and focused on its effects on the novel pro-apoptotic Noxa-reactive oxygen species (ROS) signaling pathway. CBD experiments were performed using the CRC cell lines HCT116 and DLD-1. CBD induced apoptosis by regulating many pro- and anti-apoptotic proteins, of which Noxa showed significantly higher expression. To understand the relationship between Noxa and CBD-induced apoptosis, Noxa levels were downregulated using siRNA, and the expression of apoptosis markers decreased. After ROS production was blocked, the level of Noxa also decreased, suggesting that ROS is involved in the regulation of Noxa, which along with ROS is a well-known pro-apoptotic signaling agents. As a result, CBD induced apoptosis in a Noxa-and-ROS-dependent manner. Taken together, the results obtained in this study re-demonstrated the effects of CBD treatment in vivo, thus confirming its role as a novel, reliable anticancer drug.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 3. Graduate School > Graduate School > 1. Journal Articles
- 4. Research institute > Institute of Convergence New Drug Development > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.